Hixon JA - Search Results

1

Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors.

Khan T, Stauffer JK, Williams R, Hixon JA, Salcedo R, Lincoln E, Back TC, Powell D, Lockett S, Arnold AC, Sayers TJ, Wigginton JM. Khan T, et al. Among authors: hixon ja. J Immunol. 2006 May 15;176(10):6302-12. doi: 10.4049/jimmunol.176.10.6302. J Immunol. 2006. PMID: 16670342

2

T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus.

Siders WM, Wright PW, Hixon JA, Alvord WG, Back TC, Wiltrout RH, Fenton RG. Siders WM, et al. Among authors: hixon ja. J Immunol. 1998 Jun 1;160(11):5465-74. J Immunol. 1998. PMID: 9605149

3

Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.

Fenton RG, Hixon JA, Wright PW, Brooks AD, Sayers TJ. Fenton RG, et al. Among authors: hixon ja. Cancer Res. 1998 Aug 1;58(15):3391-400. Cancer Res. 1998. PMID: 9699671

4

Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-gamma and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2.

Wigginton JM, Lee JK, Wiltrout TA, Alvord WG, Hixon JA, Subleski J, Back TC, Wiltrout RH. Wigginton JM, et al. Among authors: hixon ja. J Immunol. 2002 Oct 15;169(8):4467-74. doi: 10.4049/jimmunol.169.8.4467. J Immunol. 2002. PMID: 12370382

5

Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses.

Murphy WJ, Welniak L, Back T, Hixon J, Subleski J, Seki N, Wigginton JM, Wilson SE, Blazar BR, Malyguine AM, Sayers TJ, Wiltrout RH. Murphy WJ, et al. J Immunol. 2003 Mar 1;170(5):2727-33. doi: 10.4049/jimmunol.170.5.2727. J Immunol. 2003. PMID: 12594303

6

IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells.

Salcedo R, Stauffer JK, Lincoln E, Back TC, Hixon JA, Hahn C, Shafer-Weaver K, Malyguine A, Kastelein R, Wigginton JM. Salcedo R, et al. Among authors: hixon ja. J Immunol. 2004 Dec 15;173(12):7170-82. doi: 10.4049/jimmunol.173.12.7170. J Immunol. 2004. PMID: 15585838

7

Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma.

Khan T, Hixon JA, Stauffer JK, Lincoln E, Back TC, Brenner J, Lockett S, Nagashima K, Powell D, Wigginton JM. Khan T, et al. Among authors: hixon ja. J Natl Cancer Inst. 2006 Feb 1;98(3):190-202. doi: 10.1093/jnci/djj021. J Natl Cancer Inst. 2006. PMID: 16449679

8

Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumors.

Stauffer JK, Khan T, Salcedo R, Hixon JA, Lincoln E, Back TC, Wigginton JM. Stauffer JK, et al. Among authors: hixon ja. J Immunother. 2006 Mar-Apr;29(2):151-64. doi: 10.1097/01.cji.0000190167.76663.c7. J Immunother. 2006. PMID: 16531816

9

Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow.

Salcedo R, Hixon JA, Stauffer JK, Jalah R, Brooks AD, Khan T, Dai RM, Scheetz L, Lincoln E, Back TC, Powell D, Hurwitz AA, Sayers TJ, Kastelein R, Pavlakis GN, Felber BK, Trinchieri G, Wigginton JM. Salcedo R, et al. Among authors: hixon ja. J Immunol. 2009 Apr 1;182(7):4328-38. doi: 10.4049/jimmunol.0800471. J Immunol. 2009. PMID: 19299733 Free PMC article.

10

High-throughput molecular and histopathologic profiling of tumor tissue in a novel transplantable model of murine neuroblastoma: new tools for pediatric drug discovery.

Stauffer JK, Orentas RJ, Lincoln E, Khan T, Salcedo R, Hixon JA, Back TC, Wei JS, Patidar R, Song Y, Hurd L, Tsokos M, Lai EW, Eisenhofer G, Weiss W, Khan J, Wigginton JM. Stauffer JK, et al. Among authors: hixon ja. Cancer Invest. 2012 Jun;30(5):343-63. doi: 10.3109/07357907.2012.664670. Cancer Invest. 2012. PMID: 22571338 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters